153 related articles for article (PubMed ID: 16831554)
1. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer.
Narayanasamy S; Thirumamagal BT; Johnsamuel J; Byun Y; Al-Madhoun AS; Usova E; Cosquer GY; Yan J; Bandyopadhyaya AK; Tiwari R; Eriksson S; Tjarks W
Bioorg Med Chem; 2006 Oct; 14(20):6886-99. PubMed ID: 16831554
[TBL] [Abstract][Full Text] [Related]
2. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors.
Byun Y; Thirumamagal BT; Yang W; Eriksson S; Barth RF; Tjarks W
J Med Chem; 2006 Sep; 49(18):5513-23. PubMed ID: 16942024
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.
Agarwal HK; McElroy CA; Sjuvarsson E; Eriksson S; Darby MV; Tjarks W
Eur J Med Chem; 2013 Feb; 60():456-68. PubMed ID: 23318906
[TBL] [Abstract][Full Text] [Related]
5. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
6. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
7. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
Appl Radiat Isot; 2004 Nov; 61(5):1125-30. PubMed ID: 15308203
[TBL] [Abstract][Full Text] [Related]
8. N3-substituted thymidine bioconjugates for cancer therapy and imaging.
Khalil A; Ishita K; Ali T; Tjarks W
Future Med Chem; 2013 Apr; 5(6):677-92. PubMed ID: 23617430
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties.
Johnsamuel J; Lakhi N; Al-Madhoun AS; Byun Y; Yan J; Eriksson S; Tjarks W
Bioorg Med Chem; 2004 Sep; 12(18):4769-81. PubMed ID: 15336255
[TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.
Barth RF; Yang W; Wu G; Swindall M; Byun Y; Narayanasamy S; Tjarks W; Tordoff K; Moeschberger ML; Eriksson S; Binns PJ; Riley KJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17493-7. PubMed ID: 18981415
[TBL] [Abstract][Full Text] [Related]
11. Carboranyl thymidine analogues for neutron capture therapy.
Tjarks W; Tiwari R; Byun Y; Narayanasamy S; Barth RF
Chem Commun (Camb); 2007 Dec; (47):4978-91. PubMed ID: 18049729
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer.
Agarwal HK; Khalil A; Ishita K; Yang W; Nakkula RJ; Wu LC; Ali T; Tiwari R; Byun Y; Barth RF; Tjarks W
Eur J Med Chem; 2015 Jul; 100():197-209. PubMed ID: 26087030
[TBL] [Abstract][Full Text] [Related]
13. Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.
Sjuvarsson E; Damaraju VL; Mowles D; Sawyer MB; Tiwari R; Agarwal HK; Khalil A; Hasabelnaby S; Goudah A; Nakkula RJ; Barth RF; Cass CE; Eriksson S; Tjarks W
J Pharmacol Exp Ther; 2013 Nov; 347(2):388-97. PubMed ID: 24006340
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
Tjarks W; Wang J; Chandra S; Ji W; Zhuo J; Lunato AJ; Boyer C; Li Q; Usova EV; Eriksson S; Morrison GH; Cosquer GY
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):695-8. PubMed ID: 11563094
[TBL] [Abstract][Full Text] [Related]
15. 3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy.
Byun Y; Narayanasamy S; Johnsamuel J; Bandyopadhyaya AK; Tiwari R; Al-Madhoun AS; Barth RF; Eriksson S; Tjarks W
Anticancer Agents Med Chem; 2006 Mar; 6(2):127-44. PubMed ID: 16529536
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy.
Al-Madhoun AS; Johnsamuel J; Barth RF; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6280-6. PubMed ID: 15342416
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 3'-carboranyl thymidine analogues.
Yan J; Naeslund C; Al-Madhoun AS; Wang J; Ji W; Cosquer GY; Johnsamuel J; Sjöberg S; Eriksson S; Tjarks W
Bioorg Med Chem Lett; 2002 Aug; 12(16):2209-12. PubMed ID: 12127539
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective.
Khalil A; Adam MSS
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37818562
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Nakkula RJ; Byun Y; Tjarks W; Wu LC; Binns PJ; Riley KJ
Appl Radiat Isot; 2015 Dec; 106():251-5. PubMed ID: 26282567
[TBL] [Abstract][Full Text] [Related]
20. Charge dependent substrate activity of C3' and N3 functionalized, organometallic technetium and rhenium-labeled thymidine derivatives toward human thymidine kinase 1.
Struthers H; Viertl D; Kosinski M; Spingler B; Buchegger F; Schibli R
Bioconjug Chem; 2010 Apr; 21(4):622-34. PubMed ID: 20359195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
